SCAN 2025 is now open – we need your voice.
As a proud member of the International Neuroendocrine Cancer Alliance (INCA), NeuroEndocrine Cancer Australia is excited to share that the Survey of Challenges in Access to Diagnostics and Treatment for NET Patients (SCAN) 2025 is now open to patients, carers and healthcare professionals – and we need your voice.
Building on the success of SCAN 2019, which became the largest compendium of NET patient data ever collected, SCAN 2025 aims to go even further. By capturing lived experiences, treatment pathways and care challenges, this survey will help shine a spotlight on where improvements are most needed – both here in Australia and around the world.
SCAN 2025 will focus on key measures , including:
- The availability of NET diagnostic tools
- The level of access to NET treatments
- The level of access to ongoing checks
- The level of access to healthcare professionals
- Out-of-pocket costs of NET treatment and care
- The provision of supportive services
- Leading healthcare issues NET patients face today
Why Participate?
- Your input will help spotlight gaps in care and access for NET patients worldwide.
- Results will drive advocacy and change at a global and national level.
- The more voices we hear, the stronger our case for better outcomes.
Survey Details.
- Open from 1 September – 30 November 2025
- For patients, carers and healthcare professionals
- Available in 15 languages: English, Arabic, Bulgarian, simplified Chinese, traditional Chinese, Dutch, French, German, Hindi, Italian, Japanese, Portuguese, Russian, Spanish and Swahili.
